Menopause Position Statements

“If you would like to find out what menopause
position statements are applicable to you, it may be
in your best interest to choose to talk to your…”. Meno Martha

Umbrella
What may the Menopause Position Statements Umbrella include?

Depending on the Source (DotS) this Umbrella may include:

  • Clinical Guides
  • Consensus Statements
  • Final Recommendation Statements
  • Global Consensus Statements
  • Guidelines
  • Other Reports
  • Position Papers
  • Position Statements
  • Recommendations
  • Reports
  • Statements
  • White Paper

Date

Menopause Position StatementsWhat can it be important to be clear about with menopause position statements?

It can be important to be clear about the date of all information including the date of menopause position statements because this information may have been updated or retired.

Health Care Provider

What if I would like to find out what menopause position statement information is applicable to me?

If you would like to find out what menopause position statements are applicable to you, it may be in your best interest to choose to talk to your health care provider about this.

Health Topics A-Z

Where may I find Health Topics related to Menopause Position Statements?

In Health Topics A-Z you may find:

Health Topics A-Z

Links

Where may I find Links related to Menopause Position Statements?

Your Country may have Links similar to:

Links

This Links List to third party websites is neither comprehensive nor exhaustive. Inclusion on this Links List does not imply endorsement or recommendation. Non-inclusion on this Links List does not imply non-endorsement or non-recommendation. Third party websites are not under the control of Meno Martha International Menopause Directory. Third party websites may contain explicit medical images and/or sexual references. Please read Meno Martha International Menopause Directory’s Links Policy before proceeding to a Link. Please contact Webmaster if you experience a problem with a Link.

 
BMS   = British Menopause Society
EMAS = European Menopause and Andropause Society
IGCS  = International Gynecologic Cancer Society
IMS    = International Menopause Society

  1. 2016 IMS Recommendations on Women’s Midlife Health and Menopause Hormone Therapy
  2. Abnormal Uterine Bleeding In Perimenopause
  3. Assessment and Management of Bone Health In Women With Oestrogen Receptor-Positive Breast Cancer Receiving Endocrine Therapy
  4. BMS & WHC’s 2020 Recommendations on Hormone Replacement Therapy In Menopausal Women
  5. BMS Council Issues A Consensus Statement on Bioidentical Hormones
  6. BMS Vision: Vision for Menopause Care In the United Kingdom
  7. BMS, IMS, EMAS, RCOG and AMS Joint Statement on Menopausal Hormone Therapy (MHT) and Breast Cancer Risk
  8. Bioidentical HRT [British Menopause Society]
  9. British Menopause Society Tool for Clinicians: Testosterone Replacement In Menopause
  10. Calcium In the Prevention of Postmenopausal Osteoporosis: EMAS Guide
  11. Cardiovascular Health After Menopause Transition, Pregnancy Disorders, and Other Gynaecologic Conditions: A Consensus Document From European Cardiologists, Gynaecologists, and Endocrinologists
  12. Cardiovascular Risk Assessment In Women – An Update
  13. Clinical Practice Guidelines on Menopause: *An Executive Summary and Recommendations: Indian Menopause Society 2019–2020
  14. Clinical Practice Guidelines on Postmenopausal Osteoporosis: *An Executive Summary and Recommendations – Update 2019–2020 [Indian Menopause Society]
  15. Compounded Bioidentical Hormones In Endocrinology Practice: An Endocrine Society Scientific Statement
  16. Current Management of Pelvic Organ Prolapse In Aging Women: EMAS Clinical Guide
  17. Drug Holidays From Bisphosphonates and Denosumab In Postmenopausal Osteoporosis
  18. EMAS Clinical Guides
  19. EMAS Position Statement: Menopause Symptom Management In Women With Dyslipidemias
  20. EMAS Position Statement: Predictors of Premature and Early Natural Menopause
  21. EMAS Position Statements
  22. Eligibility Criteria for Menopausal Hormone Therapy (MHT): A Position Statement From A Consortium of Scientific Societies for the Use of MHT In Women With Medical Conditions. MHT Eligibility Criteria Group
  23. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) Position Statement on Managing the Menopause After Gynecologic Cancer: Focus on Menopausal Symptoms and Osteoporosis
  24. Global Consensus Position Statement on the Use of Testosterone Therapy for Women
  25. Global Consensus Recommendations on Menopause In the Workplace: A European Menopause and Andropause Society (EMAS) Position Statement
  26. Global Consensus Statement on Menopausal Hormone Therapy
  27. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations
  28. Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions
  29. Info for Professionals: Clinical Practice Guidelines [Indian Menopause Society]
  30. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder In Women
  31. Joint BMS, FSRH, RCGP and RCOG Position Statement on the Supply Shortages of Hormone Replacement Therapy (HRT)
  32. Joint Position Statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on Best Practice Recommendations for the Care of Women Experiencing the Menopause
  33. Management of Depressive Symptoms In Peri- and Postmenopausal Women: EMAS Position Statement
  34. Management of Osteoporosis In Postmenopausal Women: The 2021 Position Statement of The North American Menopause Society
  35. Management of Postmenopausal Women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d’Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines
  36. Management of Urinary Incontinence In Postmenopausal Women: EMAS Clinical Guide
  37. Menopausal Hormone Therapy and Breast Cancer Risk: Individualization Is the Key To Safety
  38. Menopause and Diabetes: EMAS Clinical Guide
  39. Menopause, Wellbeing and Health: A Care Pathway From the European Menopause and Andropause Society
  40. Menopause: Diagnosis and Management [NICE Guideline In Development [GID-NG10241] Expected Publication Date: 23 August 2023]
  41. Menopause: Diagnosis and Management [NICE Guideline NG 23]
  42. NICE Sets Out Further Details on Menopause Guideline Update
  43. New Menopause Practice Standards
  44. NonHormonal Management of Menopause-Associated Vasomotor Symptoms: 2015 Position Statement of the North American Menopause Society
  45. Optimising the Menopause Transition: Joint Position Statement By the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on Best Practice Recommendations for the Care of Women Experiencing the Menopause
  46. Pharmacological Management of Osteoporosis In Postmenopausal Women Guideline Resources
  47. Position Papers and Consensus Statements [International Menopause Society]
  48. Position Statement on Improving Bone Health and Osteoporosis Management In Australia
  49. Position Statements & Other Reports [North American Menopause Society]
  50. Position Statements [Australasian Menopause Society]
  51. Premature Ovarian Insufficiency [British Menopause Society]
  52. Preventing Obesity in Midlife Women: A Recommendation From the Women’s Preventive Services Initiative
  53. Prevention and Treatment of Osteoporosis In Women [British Menopause Society]
  54. Primary Prevention of Coronary Heart Disease In Women [British Menopause Society]
  55. RCGP, RCOG and BMS Position Statement on the Menopause
  56. Revised Global Consensus Statement on Menopausal Hormone Therapy
  57. The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society
  58. The 2022 Hormone Therapy Position Statement of The North American Menopause Society
  59. The British Menopause Society & Women’s Health Concern 2020 Recommendations on Hormone Replacement Therapy In Menopausal Women
  60. The Essential Menopause Curriculum for Healthcare Professionals: A European Menopause and Andropause Society (EMAS) Position Statement
  61. The Mediterranean Diet and Menopausal Health: An EMAS Position Statement
  62. The North American Menopause Society Releases Its 2022 Hormone Therapy Position Statement
  63. The Silence and the Stigma: Menopause In Canada
  64. Topical Estrogens and Non-Hormonal Preparations for Postmenopausal Vulvovaginal Atrophy: An EMAS Clinical Guide
  65. Use of Compounded Hormone Therapy In the United States: Report of the North American Menopause Society Survey
  66. World Menopause Day 2018 – Sexual Well-Being After Menopause: An International Menopause Society White Paper [Multiply Languages]
  67. World Menopause Day 2019 – Global Consensus Position Statement on the Use of Testosterone Therapy for Women: A White Paper [Multiply Languages]
  68. World Menopause Day: Brain Fog In Menopause: A Health Care Professional’s Guide for Decision Making and Counselling on Cognition: The IMS White Paper
  69. World Menopause Day: Patient Information Leaflet: Brain Fog and Memory Difficulties In Menopause

Topic Last Updated: 07 December 2022 – Topic Last Reviewed: 07 December 2022
Print Friendly, PDF & Email
/by